Hansal Mehta reveals secret to 10 kg weight loss: Mounjaro, intermittent fasting, high-protein meals and less alcohol
Filmmaker Hansal Mehta got candid with fans and social media followers about his weight loss. On May 1, he took to X to open up about his experience with Mounjaro, a medication used to treat type 2 diabetes, which also leads to weight loss. Apart from starting Mounjaro, Hansal shared that 'high-protein meals, minimal sugar and alcohol, regular strength training, proper hydration, 14-18 hour intermittent fasting' helped him lose 'nearly 10 kilos in just a few months'. Also read | Karan Johar breaks silence on rumours of 'using Ozempic for fast weight loss'
Sharing recent pictures of his leaned physique, Hansal shared that he started Mounjaro because of health concerns, and said, 'Under medical guidance, I began Mounjaro to address rising blood sugar levels in the pre-diabetic range and to manage my steadily increasing weight. Paired with a committed lifestyle shift — high-protein meals, minimal sugar and alcohol, regular strength training, proper hydration, 14-18 hour intermittent fasting, NMN + Resveratrol supplements, and better sleep — I've seen tangible results.'
He added, 'In just a few months, I'm down nearly 10 kilos. My muscle mass has significantly improved, my energy levels are higher, and my blood sugar readings are now well within the normal range. Insulin resistance has dropped, and yes, the old clothes are falling off!'
Check out his tweet:
GLP-1 drugs, like Ozempic and Mounjaro, have become popular among celebs for weight loss, both for those who only need to lose a few pounds as well as for those who have been open about their long-term weight struggles. Hansal is among the few Indian celebs who have been honest about using these weight loss drugs.
The filmmaker further opened up about the reasons he was going public with his Mounjaro journey: 'I'm sharing this because there's unnecessary stigma around these new medications and people who do use them falsely connect their new found health to ambiguous and often frustrating fitness regimens. There's no shame in taking charge of your health with the tools available to you—especially when done responsibly and under supervision. If you're struggling with similar issues, speak to your healthcare provider. It might just be the beginning of a journey you'll be grateful for. I'm on that journey—and I'm genuinely enjoying the ride. Here are some random pictures from the journey…'
Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Click here to know everything about it.
Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
9 hours ago
- First Post
New cases over 4,000, India holds Covid mock drill today for hospital checks
On Wednesday, India recorded 276 new Covid cases, with seven deaths in the past 24 hours. The highest toll was recorded in Maharashtra at four and one fatality each in Tamil Nadu, Delhi and Gujarat. The total number of deaths now stands at 44 read more A doctor inspects an isolation ward prepared for the patients with Covid-19 symptoms at a government hospital in Secunderabad in Telangana. AFP The central government has ordered facility-level mock drills in various hospitals on Thursday to assess the preparedness of healthcare services amid a rising cases of Covid-19. Active Covid cases have crossed the 4,000-mark, as per data provided by the Ministry of Health and Family Welfare. On Wednesday, India recorded 276 new Covid cases, with seven deaths in the past 24 hours. The highest toll was recorded in Maharashtra at four and one fatality each in Tamil Nadu, Delhi and Gujarat. The total number of deaths now stands at 44. STORY CONTINUES BELOW THIS AD All states have been instructed to ensure availability of oxygen, isolation beds, ventilators and essential medicines in view of rising cases of Covid. A series of technical review meetings were held on June 2 and 3 under the chairpersonship of Director General of Health Services (DGHS) Dr Sunita Sharma. The meeting was held with representatives of Disaster Management Cell, Emergency Management Response (EMR) Cell, National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), Integrated Disease Surveillance Programme (IDSP) and central government hospitals in Delhi and with representatives from all states and Union territories to evaluate the current Covid situation and preparedness measures. The upcoming drill will assess readiness in key areas, including isolation wards, oxygen supply, ventilator availability, and essential medications. Its goal is to ensure hospitals are well-prepared to respond efficiently in the event of another surge in cases. Meanwhile, a mock drill assessing oxygen supply systems (PSA plants, LMO tanks, MGPS lines) was conducted on June 2. What's triggering new cases? The subvariant JN.1 is making up 16.3 per cent of sequenced cases in the epidemiological week ending February 2. Authorities in Singapore have reported that two JN.1 descendant lineages — LF.7 and NB.1.8 — now account for over two-thirds of locally sequenced cases. However, they clarified that 'there is no indication that the variants circulating locally are more transmissible or cause more severe disease compared to previously circulating variants.' While the rampant spread of the virus has been kept in check for a long time, SARS-CoV-2, the virus responsible for Covid-19, has not disappeared entirely. Earlier this month, when a rise in cases was being reported in Singapore, authorities said that periodic waves of Covid-19 can be expected throughout the year. STORY CONTINUES BELOW THIS AD With inputs from agencies
Time of India
a day ago
- Time of India
Navigating the JN.1 Wave: A Data-Driven Blueprint for India's Healthcare Ecosystem
India's COVID-19 landscape is once again in flux. As of May 2025, the JN.1 subvariant dominates the national caseload, accounting for over half of all sequenced infections . While the current wave is less severe than the devastating Delta surge of 2021, the numbers and nuances behind this resurgence demand a sober, data-driven response. It's an opportunity to refine our strategies and build a more resilient healthcare system. The JN.1 Surge: Numbers That Matter The JN.1 strain—a descendent of the BA.2.86 lineage—has outpaced earlier variants due to its enhanced transmissibility and partial immune escape INSACOG data shows JN.1 now comprises 53 per cent of sequenced samples in India, with BA.2 and other Omicron sub lineages trailing behind . Daily new infections, while officially modest (257 active cases as per government reporting), are widely believed to be undercounted, especially in urban clusters of Kerala, Karnataka, and Maharashtra, where local spikes and test positivity rates have exceeded 16 per cent in some areas Crucially, while most cases remain mild—mirroring trends seen in Singapore and Hong Kong—there is a notable reinfection rate, a testament to JN.1's immune-evasion capabilities . Hospitalisations are significantly lower than during previous peaks, but the variant's ability to slip past existing antibodies means that complacency is not an option .We've learned valuable lessons from past waves, and we can apply them to navigate this one effectively. Vaccination remains our strongest shield, yet just 32 per cent of eligible adults have received a fourth dose, leaving hundreds of millions exposed to potential complications . Encouraging wider adoption of booster doses is a key priority. The case fatality rate hovers at 0.4 per cent, with the vast majority of deaths occurring among the unvaccinated and those with comorbidities such as diabetes and hypertension . This highlights the importance of targeted interventions for vulnerable populations. Industry-Wide Preparedness: Three Pillars 1. Infrastructure and Resource Optimization India's hospital ecosystem is adapting. Leading private hospitals have maintained 30–40 per cent surge-ready beds, compared to just 10–15 per cent in public facilities—a gap that is even more pronounced in tier-2 and tier-3 cities . Strengthening infrastructure in public facilities, particularly in underserved areas, is crucial for equitable access to care. National stockpiles of antivirals like Paxlovid are being managed with rapid replenishment cycles, and telehealth now handles a quarter of mild COVID cases, reducing pressure on physical infrastructure . 2. Financial Resilience and Insurance Gaps The pandemic has laid bare India's chronic underinsurance: nearly 70 per cent of the population lacks health insurance and relies on government facilities, leading to catastrophic out-of-pocket expenses for many . Expanding health insurance coverage is essential for financial security and access to quality healthcare. Public-private partnerships (PPPs)—such as Ayushman Bharat 's empanelment of over 12,000 private beds—are a lifeline, but coverage and awareness remain patchy, especially outside major metros . We need to continue fostering these partnerships and improving awareness of available resources. 3. Workforce Readiness Urban hospitals have improved staff-to-patient ratios, but rural areas still lag, and burnout remains a concern despite recent improvements . Mandatory leave cycles and mental health stipends have halved burnout rates since 2023, but long-term resilience will require systemic investment in healthcare workers. Supporting our healthcare workforce is paramount. We must prioritize their well-being and invest in their training and development. Bridging the Health Insurance Divide With over 930 million Indians dependent on public healthcare, insurance reform is non-negotiable . Ayushman Bharat (PMJAY) offers ₹5 lakh coverage per family per year, but only 45 per cent of eligible families are enrolled, hampered by barriers in awareness and accessibility . Pilot micro-insurance schemes in Maharashtra and Tamil Nadu are showing promise, offering daily plans as low as ₹5 for informal workers. Government proposals to cap private COVID treatment costs at 110% of CGHS rates could prevent financial ruin for millions . These initiatives demonstrate a commitment to expanding access to affordable healthcare, and we should explore further opportunities to build on this progress. Community Mobilization: Lessons from the Frontlines The success of India's vaccination drives has hinged on relentless community engagement. Door-to-door campaigns in states like Uttar Pradesh and Bihar have boosted fourth-dose coverage, while mobile testing vans in Odisha and Chhattisgarh have improved rural diagnostics and early containment . Targeted awareness campaigns—leveraging WhatsApp, community radio, and local influencers—have chipped away at vaccine hesitancy, which has dropped from 28 per cent to 12 per cent in some states . These successes underscore the power of community-based approaches. We should continue to invest in these strategies and tailor them to local needs. A Call to Collective Action The JN.1 wave is a litmus test for India's healthcare equity. Three imperatives stand out: Boost vaccination coverage: Target a 50 per cent fourth-dose uptake by December 2025 (currently at 32 per cent). This is an ambitious but achievable goal that requires a concerted effort from all stakeholders. Strengthen public infrastructure: Allocate at least 30 per cent of health budgets to district hospitals and primary health centers, especially in underserved regions. Investing in public health infrastructure is a long-term strategy that will benefit all data analytics: Real-time genomic sequencing of at least 10 per cent of cases must guide hotspot interventions and resource allocation. Data-driven decision-making is essential for an effective and efficient response. Conclusion: Equity as the Foundation of Resilience Pandemics amplify systemic inequities. For India, resilience depends on merging the efficiency of the private sector with the reach of public health systems. As we navigate the JN.1 wave, let's ensure that no Indian—insured or uninsured—is left behind. The blueprint is clear: data-driven policy, robust insurance, and community mobilization are not just options, but working together, we can build a more equitable and resilient healthcare system for all. Stay informed. Stay united. This article is written by Anurag Yadav , CEO, Gleneagles Healthcare India (DISCLAIMER: The views expressed are solely of the author and does not necessarily subscribe to it. shall not be responsible for any damage caused to any person/organisation directly or indirectly)
NDTV
a day ago
- NDTV
Ozempic Users Flock To Protein Shake Now Named America's Unhealthiest Bottled Drink
Water is the best way to hydrate, but if you're craving something else, be cautious. Many bottled drinks like juice and protein shakes may seem healthy, but they're often high in sugar. These convenient drinks can exceed daily recommended sugar intake, making them a less healthy choice than they appear. Fairlife's Core Power protein shakes have been named the unhealthiest bottled beverage in America by food and nutrition magazine Eat This, Not That!, despite their popularity among fitness enthusiasts and Ozempic users. The shakes' muscle-boosting reputation is overshadowed by concerns over their nutritional content, sparking surprise and concern among consumers. A news portal consulted dietitian Mary Sabat, MS, RDN, LD, who identified the seven unhealthiest food choices-ranking Core Power Protein Shakes as the worst among them for health impact. They are a go-to for many after a workout or to boost their protein intake, but Sabat says these drinks are highly problematic. "I put these first because they are so highly marketed as a great source of protein and a healthy food when in reality they are a disaster to your metabolic health," Sabat says. "Core Power Protein Shakes may seem like a convenient post-workout drink, but a closer look at the ingredients reveals several health concerns." She explains, "They use non-organic, conventional dairy, which often comes from cows fed GMO corn and soy and may contain residues of hormones and antibiotics-unlike grass-fed dairy, which is higher in omega-3s and CLA and free from harmful residues. The addition of carrageenan, a thickening agent linked to gut inflammation and irritation, further detracts from its health profile." Sabat also points out other harmful ingredients. "Artificial sweeteners like sucralose and acesulfame potassium are also used, both of which have been associated with gut microbiome disruption and potential carcinogenic effects in animal studies," she says. Sabat adds, "Lastly, the label includes 'natural flavours," a term that can encompass up to 100 different undisclosed chemical additives, many of which are far from natural. Together, these ingredients make Core Power far less healthy than its marketing implie"s.
